CIK: 0002013410
Total reported value
$722.2M
Reporting period: 2026-03-31 · Number of holdings: 14
FCPM III SERVICES B.V. disclosed 14 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $722.2M and a quarterly turnover rate of 34.9%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "F"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add VOR
+13.8% $26.1M
Trim DYN
-15.0% -$22.7M
Trim 29286M105
0.0% -$21.4M
Add G2545C104
0.0% $10.9M
Add MPLT
0.0% $8.9M
Trim NAMS
0.0% -$28.2M
Showing top 10 holdings (of 14 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 40.77% | -1.53% | — | |
| 2 | DYN | Dyne Therapeutics INC | Stock-Other | 11.66% | -2.35% | -14.98% | |
| 3 | VOR | Vor Biopharma INC | Stock-Other | 10.17% | +3.97% | +13.82% | |
| 4 | ✓ | Engene Holdings INC | Stock-Other | 9.08% | -2.32% | — | |
| 5 | MPLT | Maplight Therapeutics INC | Stock-Other | 9.08% | +1.65% | — | |
| 6 | DMRA | Damora Therapeutics INC | Stock-Other | 8.75% | +8.75% | NEW | |
| 7 | ✓ | Crescent Biopharma INC. | Stock-Other | 4.27% | +1.66% | — | |
| 8 | REPL | Replimune Group INC | Stock-Other | 2.97% | -0.61% | — | |
| 9 | BCYC | Bicycle Therapeutics Plc-adr | Stock-Other | 2.23% | -0.99% | — | |
| 10 | ✓ | Engene Holdings INC | Stock-Other | 1.01% | -0.11% | — |
Performance for Q3 2026
+18.7%
Performance Last 4 Quarters
+62.6%
Based on 65% of reported portfolio value with available pricing
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 14 | $722.2M | 35 | |
| 2025-12-31 | 14 | $762.9M | 52 | |
| 2025-09-30 | 13 | $500.4M | 31 | |
| 2025-06-30 | 12 | $369.2M | 0 | |
| 2025-03-31 | 12 | $413.7M | 0 | |
| 2024-12-31 | 12 | $592.4M | 0 | |
| 2024-09-30 | 11 | $582.3M | 0 | |
| 2024-06-30 | 11 | $678.1M | 0 | |
| 2024-03-31 | 10 | $707.3M | 0 | |
| 2023-12-31 | 9 | $339.4M | 0 |
Fcpm Iii Services B.v.'s most significant position changes for 2026-03-31: New buy: Damora Therapeutics INC (DMRA); Sold out: Rapt Therapeutics INC (RAPT); Add: Vor Biopharma INC (VOR) — shares +13.82%; Trim: Dyne Therapeutics INC (DYN) — shares -14.98%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | VOR | Vor Biopharma INC | +4% | +13.82% | Add |
| 2 | ✓ | Crescent Biopharma INC. | +1.7% | — | Unchanged |
| 3 | MPLT | Maplight Therapeutics INC | +1.7% | — | Unchanged |
| 4 | ✓ | Engene Holdings INC | -0.1% | — | Unchanged |
| 5 | REPL | Replimune Group INC | -0.6% | — | Unchanged |
| 6 | BCYC | Bicycle Therapeutics Plc-adr | -1% | — | Unchanged |
| 7 | NAMS | NewAmsterdam Pharma Company N.V. | -1.5% | — | Unchanged |
| 8 | ✓ | Engene Holdings INC | -2.3% | — | Unchanged |
| 9 | DYN | Dyne Therapeutics INC | -2.4% | -14.98% | Trim |
| 10 | DMRA | Damora Therapeutics INC | — | NEW | New buy |
| 11 | RAPT | Rapt Therapeutics INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-17 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-08 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-03 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-03-07 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001533950
Total reported value
$722.2M
61 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001541349
Total reported value
$721.8M
88 stks
2022-03-31
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0002011237
Total reported value
$722.7M
260 stks
2026-06-30
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001263048
Total reported value
$44.5M
4 stks
2025-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Dyne Therapeutics INC
CIK 0001281446
Total reported value
$435.1M
42 stks
2026-03-31
1 of the top 5 holdings overlap, including Vor Biopharma INC
CIK 0001388325
Total reported value
$1.2B
22 stks
2026-03-31
1 of the top 5 holdings overlap, including Maplight Therapeutics INC